Pfizer seeks emergency approval for COVID-19 vaccine in India

Pfizer Inc has applied for emergency use authorization of its coronavirus vaccine in India, media said on Sunday, the first to do so in a country with the world’s second-highest number of infections.

The U.S. company, whose vaccine was recently approved by the British government, has written to the Drugs Controller General of India (DCGI), according to CNN-News18 citing a government source, Reuters reported.

Officials at the DCGI and the health ministry did not respond to requests for comment. A government official, however, no application had been received as of Saturday night.

Pfizer could not immediately be reached.

Comments